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JAAD ONLINE: NOTES &
Reply to ‘‘Local recurrence of
clinically observed basal cell
carcinomas following complete
saucerization or punch removal
with negative margins:
Retrospective case series from 2010
to 2020’’
To the Editor: We read with interest the article by
Ransohoff et al,1 suggesting that ‘‘biopsy with
excisional intent’’ may be curative for majority of
lower-risk basal cell carcinomas (BCCs).1 As the
incidence of nonmelanoma skin cancer continues
to increase, we commend the authors for attempting
to find ways to mitigate health care costs in the face
of a growing epidemic. However, several critical
issues arose when we read this article.
The most critical issue is the concept that the
margins can be confidently assessed with routine
pathology. During standard vertical sectioning, ie,
‘‘breadloafing’’ of tissue for histopathologic evaluation, routine pathology can only examine ~1% of the
true margin.2 In fact, true surgical margin analysis is
\0.1% in most standard dermatopathology settings.
This means that [99% of the surgical margin is never
assessed during a routine pathologic assessment of
the biopsied or excised tissue.2 Thus, to confidently
claim complete removal with clear margins with a
biopsy, is impossible. This conclusion is corroborated by the fact that nearly 50% of superficial BCCs
will demonstrate a previously undetected carcinoma
of a different histologic subtype (most frequently
higher grade/more aggressive subtype), when
exhaustive sectioning or comprehensive margin
analysis is used.3 Furthermore, it has been well
documented that nearly 50% of recurrent BCCs are
a result of initial tumor misclassification during
pathologic assessment of the biopsy specimen.4 As
such, we recommend against calling a biopsied
tumor ‘‘clear,’’ if it has been grossed and processed
in a routine histopathologic fashion.
In practice, routine vertical section aka ‘‘breadloaf’’ pathologic tissue processing of the excision
specimens has provided durable tumor cure rates.
However, it is important to recognize that the key to
its success is the incorporation of a standardized
clinical ‘‘safety’’ margin utilized around the tumor
during the excision time. In other words, the reason
we can clear tumors with success using the traditional wide local excision and standard ‘‘breadloafing’’ is because of a predetermined safety margin of
benign-appearing tissue around the tumor, to account for that very shortcoming of margin analysis
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during routine pathology. Vertical sectioning technique using standard 4-mm sections can only detect
approximately 19% of the positive margins.
Additionally, there was no mention or standardization of the clinical margins used for the excisional
biopsies. The lack of standardization in prebiopsy
margins, ranging from \1 mm to [2 mm, significantly impacts recurrence rates, histopathologic subtype detected, and interpretation of ‘‘clear’’ margins
on histology. Surely, performing a ‘‘deep scoop’’
excisional biopsy with a 4 mm clinical margin around
a BCC on the arm would produce a vastly superior
tumor clearance rate than a scoop excisional biopsy
right at the clinical edge of a tumor.
In summary, accurate histopathologic margin
assessment defines treatment success or failure in
surgical oncology. Numerous studies have demonstrated the risks of interpreting margins from routine
biopsies due to the inherent inability to assess [ 99%
of the true surgical margin. As such, we caution
against declaring a tumor ‘‘clear’’ based on biopsy
margins alone.
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